In addition to this, according to previous studies, amplification of the SKP2 locus was reported in certain cancers, such as in lung cancer, biliary tract cancer, and glioblastoma [32–34], which may contribute to the upregulation of SKP2 in these cancers at transcriptional levels. Here, SKP2 is linked to lung carcinoma.